ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis

FRA:ABL • US0028241000

98.71 EUR
+0.42 (+0.43%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall ABL gets a fundamental rating of 6 out of 10. We evaluated ABL against 63 industry peers in the Health Care Equipment & Supplies industry. ABL has an excellent profitability rating, but there are some minor concerns on its financial health. ABL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ABL had positive earnings in the past year.
  • In the past year ABL had a positive cash flow from operations.
  • In the past 5 years ABL has always been profitable.
  • ABL had a positive operating cash flow in 4 of the past 5 years.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of ABL (16.60%) is better than 95.38% of its industry peers.
  • ABL's Return On Equity of 27.43% is amongst the best of the industry. ABL outperforms 95.38% of its industry peers.
  • ABL has a Return On Invested Capital of 8.88%. This is in the better half of the industry: ABL outperforms 75.38% of its industry peers.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 8.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 31.88%, ABL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • ABL's Profit Margin has improved in the last couple of years.
  • ABL's Operating Margin of 18.29% is fine compared to the rest of the industry. ABL outperforms 76.92% of its industry peers.
  • ABL's Operating Margin has improved in the last couple of years.
  • ABL has a Gross Margin (56.19%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • ABL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ABL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • ABL has an Altman-Z score of 5.46. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
  • ABL's Altman-Z score of 5.46 is amongst the best of the industry. ABL outperforms 89.23% of its industry peers.
  • The Debt to FCF ratio of ABL is 1.87, which is an excellent value as it means it would take ABL, only 1.87 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ABL (1.87) is better than 80.00% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that ABL is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.23, ABL is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.46
ROIC/WACC0.91
WACC9.79%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that ABL should not have too much problems paying its short term obligations.
  • ABL's Current ratio of 1.70 is in line compared to the rest of the industry. ABL outperforms 50.77% of its industry peers.
  • A Quick Ratio of 1.24 indicates that ABL should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.24, ABL is in line with its industry, outperforming 55.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.28% over the past year.
  • The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
  • Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
  • Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.38% yearly.
  • The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • ABL is valuated rather expensively with a Price/Earnings ratio of 22.64.
  • Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 66.15% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.07. ABL is around the same levels.
  • The Price/Forward Earnings ratio is 20.29, which indicates a rather expensive current valuation of ABL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, ABL is valued a bit cheaper.
Industry RankSector Rank
PE 22.64
Fwd PE 20.29
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA is on the same level as the industry average.
  • ABL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.29
EV/EBITDA 18.62
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ABL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.97
PEG (5Y)3.18
EPS Next 2Y10.76%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.17%, ABL has a reasonable but not impressive dividend return.
  • ABL's Dividend Yield is a higher than the industry average which is at 1.06.
  • Compared to an average S&P500 Dividend Yield of 1.82, ABL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • ABL pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
  • ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABBOTT LABORATORIES

FRA:ABL (2/27/2026, 7:00:00 PM)

98.71

+0.42 (+0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap171.64B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts80
Price Target114.26 (15.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend1.88
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-8.74%
PT rev (3m)-9.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 22.64
Fwd PE 20.29
P/S 4.62
P/FCF 29.29
P/OCF 22.22
P/B 3.98
P/tB 9.48
EV/EBITDA 18.62
EPS(TTM)4.36
EY4.42%
EPS(NY)4.86
Fwd EY4.93%
FCF(TTM)3.37
FCFY3.41%
OCF(TTM)4.44
OCFY4.5%
SpS21.36
BVpS24.82
TBVpS10.42
PEG (NY)1.97
PEG (5Y)3.18
Graham Number49.35
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 8.88%
ROICexc 9.99%
ROICexgc 19.14%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.46
F-Score8
WACC9.79%
ROIC/WACC0.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A

ABBOTT LABORATORIES / ABL.DE FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.


What is the profitability of ABL stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ABL stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 22.64 and the Price/Book (PB) ratio is 3.98.


How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 28.93%.